Cargando…

Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)

The application of patient-derived xenografts (PDX) in drug screening and testing is a costly and time-consuming endeavor. While cell lines permit extensive mechanistic studies, many human breast cancer cell lines lack patient characteristics and clinical treatment information. Establishing cell lin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Yongxian, Grainger, Jordan M., Vedell, Peter T., Yu, Jia, Moyer, Ann M., Gao, Huanyao, Fan, Xiao-Yang, Qin, Sisi, Liu, Duan, Kalari, Krishna R., Goetz, Matthew P., Boughey, Judy C., Weinshilboum, Richard M., Wang, Liewei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213738/ https://www.ncbi.nlm.nih.gov/pubmed/34145270 http://dx.doi.org/10.1038/s41523-021-00285-x

Ejemplares similares

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
por: Goetz, Matthew P., et al.
Publicado: (2017)

The novel function of tumor protein D54 in regulating pyruvate dehydrogenase and metformin cytotoxicity in breast cancer
por: Zhuang, Yongxian, et al.
Publicado: (2019)

Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer
por: Kohale, Ishwar N., et al.
Publicado: (2022)

Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy
por: Park, Jae-Hyun, et al.
Publicado: (2016)

Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall
por: Moyer, Ann M., et al.
Publicado: (2019)

Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early‐Stage Breast Cancer
por: Cairns, Junmei, et al.
Publicado: (2021)

Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors
por: Tang, Xiaojia, et al.
Publicado: (2023)

Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer
por: Wei, Lixuan, et al.
Publicado: (2023)

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study
por: Yu, Jia, et al.
Publicado: (2017)

Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study
por: Yu, Jia, et al.
Publicado: (2021)

Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer
por: Behrens, Marshall D., et al.
Publicado: (2022)

Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration‐Resistant Prostate Cancer
por: Qin, Sisi, et al.
Publicado: (2022)

A comprehensive analysis of breast cancer microbiota and host gene expression
por: Thompson, Kevin J., et al.
Publicado: (2017)

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy
por: Ellingson, Marissa S., et al.
Publicado: (2015)

NDUFA4L2 promotes trastuzumab resistance in HER2-positive breast cancer
por: Yuan, Yuan, et al.
Publicado: (2021)

Cytochrome P450 Transcriptional Regulation by Testis‐Specific Y‐Encoded‐Like Protein: Identification of Novel Upstream Transcription Factors
por: Shivaram, Suganti, et al.
Publicado: (2023)

TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer
por: Gu, Yayun, et al.
Publicado: (2022)

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
por: Thompson, Kevin J, et al.
Publicado: (2022)

ZNF423 modulates the AMP-activated protein kinase pathway and metformin response in a single nucleotide polymorphisms, estrogen and selective estrogen receptor modulator dependent fashion
por: Qin, Sisi, et al.
Publicado: (2021)

Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model
por: Mercatali, Laura, et al.
Publicado: (2016)

Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
por: Blatti, Charles, et al.
Publicado: (2023)

Regulation of sister chromatid cohesion by nuclear PD-L1
por: Yu, Jia, et al.
Publicado: (2020)

Author Correction: Regulation of sister chromatid cohesion by nuclear PD-L1
por: Yu, Jia, et al.
Publicado: (2020)

Frequency of MicroRNA Response Elements Identifies Pathologically Relevant Signaling Pathways in Triple-Negative Breast Cancer
por: Nair, Asha A., et al.
Publicado: (2020)

Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer
por: Athreya, Arjun P., et al.
Publicado: (2017)

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study
por: Wang, Liewei, et al.
Publicado: (2017)

Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients
por: Bidadi, Behzad, et al.
Publicado: (2018)

TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer
por: Qin, Sisi, et al.
Publicado: (2017)

Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes
por: Liu, Duan, et al.
Publicado: (2017)

Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment
por: Sicotte, Hugues, et al.
Publicado: (2022)

Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX
por: Rea, Domenica, et al.
Publicado: (2016)

Patient-derived xenograft (PDX) models, applications and challenges in cancer research
por: Abdolahi, Shahrokh, et al.
Publicado: (2022)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
por: Cairns, Junmei, et al.
Publicado: (2020)

Circular RNAs and their associations with breast cancer subtypes
por: Nair, Asha A., et al.
Publicado: (2016)

Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models
por: Okada, Seiji, et al.
Publicado: (2019)

Patient-derived xenograft (PDX) models: characteristics and points to consider for the process of establishment
por: Fujii, Etsuko, et al.
Publicado: (2020)

Testis- specific Y-encoded- like protein 1 and cholesterol metabolism: Regulation of CYP1B1 expression through Wnt signaling
por: Zhu, Xiujuan, et al.
Publicado: (2022)

The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1
por: Cairns, Junmei, et al.
Publicado: (2019)

Immortalization-associated gene signature in breast cancer
por: Dairkee, SH, et al.
Publicado: (2005)

Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers
por: Li, Liang, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_mgvvq31410l9hplqevc0nk4klk